Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8437555 | EBioMedicine | 2018 | 6 Pages |
Abstract
Naturally occurring genetic variation in the dopamine system can influence treatment outcomes in children with cerebral palsy. A polygenic dopamine score might be valid for treatment outcome prediction and for designing individually tailored interventions for children with cerebral palsy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Rochellys Diaz Heijtz, Rita Almeida, Ann Christin Eliasson, Hans Forssberg,